Desh Rakshak

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "35.00",
    "mcapval": "21.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE971E01016",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "13:34 PM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "600 ",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-desh-rakshak-aushdhalaya-ltd-latest-results-good-or-bad-4023976",
        "imagepath": "",
        "date": "2026-05-30 19:55:29",
        "description": "Desh Rakshak Aushdhalaya Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant sequential recovery in profitability but persistent challenges in revenue generation. The company reported a net profit of ₹0.30 crores, reflecting a notable sequential increase of 233.33% from the previous quarter. This improvement in net profit was accompanied by a substantial quarter-on-quarter revenue growth of 146.43%, rising to ₹3.45 crores from ₹1.40 crores in Q3 FY26.\n\nHowever, the year-on-year comparison highlights a decline in revenue, with a decrease of 21.41% from ₹4.39 crores in Q4 FY25. This trend raises concerns about ongoing demand challenges within the company's core Ayurvedic product portfolio. Despite the revenue volatility, Desh Rakshak demonstrated effective cost management, as evidenced by an operating margin of 17.97%, which improved from 15.43% in th..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Gains 10.65%: Key Valuation and Technical Shifts Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-gains-1065-key-valuation-and-technical-shifts-drive-momentum-4023616",
        "imagepath": "",
        "date": "2026-05-30 17:19:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens at ₹33.21, surging 5.00%</p>\n                    <p><strong>26 May:</strong> Further 5.00% gain following upgrade announcement</p>\n                    <p><strong>27 May:</strong> Price peaks at ₹36.61 (+4.99%) amid rating upgrade</p>\n                    <p><strong>29 May:</strong> Price retreats 4.40% to close week at ₹35.00</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹31.63</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹35.00</div><div class=\"stat-chan..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Q4 FY26: Profitability Rebounds Sharply But Revenue Decline Persists",
        "link": "https://www.marketsmojo.com/news/result-analysis/desh-rakshak-aushdhalaya-q4-fy26-profitability-rebounds-sharply-but-revenue-decline-persists-4022954",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_quaterlyResult_4022954.png",
        "date": "2026-05-29 22:32:49",
        "description": "Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported a mixed performance for the quarter ended March 2026, with net profit surging 233.33% quarter-on-quarter to ₹0.30 crores, yet revenue continuing to decline year-on-year by 21.41%. The micro-cap pharmaceutical company, with a market capitalisation of ₹21.00 crores, saw its stock tumble 4.40% to ₹35.00 following the results announcement, reflecting investor concerns about sustained revenue weakness despite improved profitability."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-changing-market-sentiment-4019185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_valuationdot_4019185.png",
        "date": "2026-05-29 08:00:48",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in market perception. Despite a recent 4.99% rise in share price to ₹36.61, the company’s price-to-earnings (P/E) ratio now stands at 33.11, signalling a more tempered valuation compared to its historical and peer averages."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-upgraded-to-sell-on-technical-and-valuation-improvements-4017796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_mojoScore_4017796.png",
        "date": "2026-05-28 08:27:56",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 May 2026. This change reflects a nuanced improvement across technical indicators and valuation metrics, despite ongoing challenges in financial performance and long-term fundamentals."
      },
      {
        "title": "When is the next results date for Desh Rakshak Aushdhalaya Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-desh-rakshak-aushdhalaya-ltd-4015275",
        "imagepath": "",
        "date": "2026-05-26 23:20:43",
        "description": "The next results date for Desh Rakshak Aushdhalaya Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Gains 21.47%: Valuation Shift and Downgrade Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-gains-2147-valuation-shift-and-downgrade-shape-the-week-4009075",
        "imagepath": "",
        "date": "2026-05-24 09:00:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Stock opens at Rs.27.34, surging 4.99% despite Sensex decline</p>\n                    <p><strong>19 May:</strong> Downgrade to Strong Sell announced; valuation grade upgraded</p>\n                    <p><strong>21 May:</strong> Continued strong gains with 4.98% rise to Rs.30.13</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.31.63, up 4.98% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26.04</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-va..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-valuation-signals-3998427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_mojoScore_3998427.png",
        "date": "2026-05-19 09:01:39",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. Despite an improvement in valuation metrics, the company’s weak financial trends and poor quality indicators have weighed heavily on the overall assessment, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd: Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-3997703",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeshRakshakAush_valuationdot_3997703.png",
        "date": "2026-05-19 08:00:38",
        "description": "Desh Rakshak Aushdhalaya Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, driven by changes in its price-to-earnings and price-to-book value ratios. Despite a challenging year-to-date performance and a micro-cap status, the company’s valuation now presents a compelling case for investors seeking opportunities in the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 223,
    "sid": "351394",
    "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Intimation regarding newspaper publication of financial results for the quarter and financial year ended March 31 2026 pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Intimation regarding publication of financial results for the quarter and financial year ended March 31 2026 pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Non-Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Intimation regarding non applicability of annual secretarial compliance report under Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Desh Rakshak Aushdhalaya Ltd latest results good or bad?

2026-05-30 19:55:29

Desh Rakshak Aushdhalaya Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by significant sequential recovery in profitability but persistent challenges in revenue generation. The company reported a net profit of ₹0.30 crores, reflecting a notable sequential increase of 233.33% from the previous quarter. This improvement in net profit was accompanied by a substantial quarter-on-quarter revenue growth of 146.43%, rising to ₹3.45 crores from ₹1.40 crores in Q3 FY26. However, the year-on-year comparison highlights a decline in revenue, with a decrease of 21.41% from ₹4.39 crores in Q4 FY25. This trend raises concerns about ongoing demand challenges within the company's core Ayurvedic product portfolio. Despite the revenue volatility, Desh Rakshak demonstrated effective cost management, as evidenced by an operating margin of 17.97%, which improved from 15.43% in th...

Read full news article

Desh Rakshak Aushdhalaya Ltd Gains 10.65%: Key Valuation and Technical Shifts Drive Momentum

2026-05-30 17:19:53

Key Events This Week

25 May: Stock opens at ₹33.21, surging 5.00%

26 May: Further 5.00% gain following upgrade announcement

27 May: Price peaks at ₹36.61 (+4.99%) amid rating upgrade

29 May: Price retreats 4.40% to close week at ₹35.00

Week Open

₹31.63

Week Close

₹35.00

Read full news article

Desh Rakshak Aushdhalaya Q4 FY26: Profitability Rebounds Sharply But Revenue Decline Persists

2026-05-29 22:32:49

Desh Rakshak Aushdhalaya Ltd., one of India's oldest manufacturers of pure Ayurvedic and herbal products, reported a mixed performance for the quarter ended March 2026, with net profit surging 233.33% quarter-on-quarter to ₹0.30 crores, yet revenue continuing to decline year-on-year by 21.41%. The micro-cap pharmaceutical company, with a market capitalisation of ₹21.00 crores, saw its stock tumble 4.40% to ₹35.00 following the results announcement, reflecting investor concerns about sustained revenue weakness despite improved profitability.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Changing Market Sentiment

2026-05-29 08:00:48

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in market perception. Despite a recent 4.99% rise in share price to ₹36.61, the company’s price-to-earnings (P/E) ratio now stands at 33.11, signalling a more tempered valuation compared to its historical and peer averages.

Read full news article

Desh Rakshak Aushdhalaya Ltd Upgraded to Sell on Technical and Valuation Improvements

2026-05-28 08:27:56

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 May 2026. This change reflects a nuanced improvement across technical indicators and valuation metrics, despite ongoing challenges in financial performance and long-term fundamentals.

Read full news article

When is the next results date for Desh Rakshak Aushdhalaya Ltd?

2026-05-26 23:20:43

The next results date for Desh Rakshak Aushdhalaya Ltd is scheduled for 29 May 2026....

Read full news article

Desh Rakshak Aushdhalaya Ltd Gains 21.47%: Valuation Shift and Downgrade Shape the Week

2026-05-24 09:00:55

Key Events This Week

18 May: Stock opens at Rs.27.34, surging 4.99% despite Sensex decline

19 May: Downgrade to Strong Sell announced; valuation grade upgraded

21 May: Continued strong gains with 4.98% rise to Rs.30.13

22 May: Week closes at Rs.31.63, up 4.98% on the day

Week Open

Rs.26.04

Week Close

Read full news article

Desh Rakshak Aushdhalaya Ltd Downgraded to Strong Sell Amid Mixed Financial and Valuation Signals

2026-05-19 09:01:39

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. Despite an improvement in valuation metrics, the company’s weak financial trends and poor quality indicators have weighed heavily on the overall assessment, prompting a reassessment of its investment appeal.

Read full news article

Desh Rakshak Aushdhalaya Ltd: Valuation Shifts Signal Renewed Price Attractiveness

2026-05-19 08:00:38

Desh Rakshak Aushdhalaya Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, driven by changes in its price-to-earnings and price-to-book value ratios. Despite a challenging year-to-date performance and a micro-cap status, the company’s valuation now presents a compelling case for investors seeking opportunities in the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News